Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01102478 · ClinicalTrials.gov registry record · NA
Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions
A NA study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01102478 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 30 participants.
The verdict
NCT01102478, a NA study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this study was to prove the bioequivalence of Losartan Potassium/Hydrochlorothiazide 100/25 mg tablet under fasted conditions.
Interventions
- DRUG losartan potassium / hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-02 |
| Est. Completion | 2005-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01102478
The ClinicalTrials.gov registry entry for NCT01102478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which losartan potassium / hydrochlorothiazide is the first listed.
NCT01102478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01102478 about?
NCT01102478 is a clinical study titled "Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions". The objective of this study was to prove the bioequivalence of Losartan Potassium/Hydrochlorothiazide 100/25 mg tablet under fasted conditions.
What is the current status of trial NCT01102478?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-02. Estimated completion is 2005-03.
What interventions are being tested in trial NCT01102478?
The interventions under investigation include: losartan potassium / hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT01102478?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.